BIOMAT Database Logo BIOMAT Database Logo

[Hematologic toxicity of vasodilators]. 1982

B Desablens, and J Messerschmitt

UI MeSH Term Description Entries
D008297 Male Males
D009257 Nafronyl A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors. Nafronyloxalate,Naftidrofuryl,Artocoron,Azunaftil,Di-Actane,Dusodril,Gévatran,LS-121,Nafronyl Oxalate,Nafti Von Ct,Nafti-Puren,Nafti-Ratiopharm,Naftifurin Oxalate,Naftilong,Naftilux,Praxilene,Praxilène,Di Actane,LS 121,LS121,Nafti Puren,Nafti Ratiopharm,NaftiRatiopharm,Oxalate, Nafronyl,Oxalate, Naftifurin
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

B Desablens, and J Messerschmitt
Hematologic toxicity of carbamazepine.
January 1975, Advances in neurology,
B Desablens, and J Messerschmitt
Hematologic toxicity of thiophenicol.
October 1976, La Nouvelle presse medicale,
B Desablens, and J Messerschmitt
Hematologic toxicity of chloramphenicol.
October 1969, Minnesota medicine,
B Desablens, and J Messerschmitt
Temozolomide-related hematologic toxicity.
January 2013, Onkologie,
B Desablens, and J Messerschmitt
[Drugs and hematologic toxicity].
February 1977, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
B Desablens, and J Messerschmitt
Hematologic aspects of drug toxicity.
December 1954, New York state journal of medicine,
B Desablens, and J Messerschmitt
Hematologic toxicity of sodium valproate.
January 2000, Journal of pediatric hematology/oncology,
B Desablens, and J Messerschmitt
Hematologic toxicity of immunosuppressive treatment.
April 2004, Transplantation proceedings,
B Desablens, and J Messerschmitt
[Hematologic toxicity of antidepressive agents].
January 1988, L'Encephale,
B Desablens, and J Messerschmitt
Hematologic toxicity of a chloramphenicol analogue.
July 1962, The American journal of the medical sciences,
Copied contents to your clipboard!